Comparison between MRI screening and CT-plus-MRI screening for thrombolysis within 3 h of ischemic stroke

Journal of the Neurological Sciences

Volumn 294, Issue 1-2, 2010, Pages 119-123

  Yoo, Sung Hee ^a   Kwon, Sun U ^a   Lee, Deok Hee ^a   Kim, Sang Joon ^a   Kim, Jong S ^a   Kang, Dong Wha ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Acute ischemic stroke; Computed tomography; Magnetic resonance imaging; Thrombolysis

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; FIBRINOLYTIC AGENT;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATIENT SELECTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; RATING SCALE; SCREENING TEST; BRAIN; COMPARATIVE STUDY; DRUG EFFECTS; FIBRINOLYTIC THERAPY; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY; RADIOGRAPHY; RETROSPECTIVE STUDY; STROKE; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; BRAIN; BRAIN ISCHEMIA; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PATIENT SELECTION; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 77953288813     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2010.03.015     Document Type: Article

References (15)

1. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 333 (1995) 1581-1587
2. Marler J.R., Tilley B.C., Lu M., Brott T.G., Lyden P.C., Grotta J.C., et al. Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology 55 (2000) 1649-1655
3. Hacke W., Donnan G., Fieschi C., Kaste M., von Kummer R., Broderick J.P., et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363 (2004) 768-774
4. Chalela J.A., Kang D.W., Luby M., Ezzeddine M., Latour L.L., Todd J.W., et al. Early magnetic resonance imaging findings in patients receiving tissue plasminogen activator predict outcome: insights into the pathophysiology of acute stroke in the thrombolysis era. Ann Neurol 55 (2004) 105-112
5. Kidwell C.S., Alger J.R., and Saver J.L. Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke 34 (2003) 2729-2735
6. Kidwell C.S., Chalela J.A., Saver J.L., Starkman S., Hill M.D., Demchuk A.M., et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA 292 (2004) 1823-1830
7. Kang D.W., Chalela J.A., Dunn W., and Warach S. MRI screening before standard tissue plasminogen activator therapy is feasible and safe. Stroke 36 (2005) 1939-1943
8. Kohrmann M., Juttler E., Fiebach J.B., Huttner H.B., Siebert S., Schwark C., et al. MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study. Lancet Neurol 5 (2006) 661-667
9. Ribo M., Molina C.A., Rovira A., Quintana M., Delgado P., Montaner J., et al. Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol. Stroke 36 (2005) 602-606
10. Schellinger P.D., Fiebach J.B., and Hacke W. Imaging-based decision making in thrombolytic therapy for ischemic stroke: present status. Stroke 34 (2003) 575-583
11. Thomalla G., Schwark C., Sobesky J., Bluhmki E., Fiebach J.B., Fiehler J., et al. Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials. Stroke 37 (2006) 852-858
12. Cho A.H., Sohn S.I., Han M.K., Lee D.H., Kim J.S., Choi C.G., et al. Safety and efficacy of MRI-based thrombolysis in unclear-onset stroke. A preliminary report. Cerebrovasc Dis 25 (2008) 572-579
13. Lewandowski C.A., Frankel M., Tomsick T.A., Broderick J., Frey J., Clark W., et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 30 (1999) 2598-2605
14. Albers G.W., Bates V.E., Clark W.M., Bell R., Verro P., and Hamilton S.A. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 283 (2000) 1145-1150
15. Lisboa R.C., Jovanovic B.D., and Alberts M.J. Analysis of the safety and efficacy of intra-arterial thrombolytic therapy in ischemic stroke. Stroke 33 (2002) 2866-2871